Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > LRP5(Gene name) > Human
  • Add your favorite
  • LRP5 (Gene name),
  • Low-density lipoprotein receptor-related protein 5 (Protein name ),  LRP5_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    LRP5(LRP7;LRP7);
    Protein name:
    Low-density lipoprotein receptor-related protein 5(LRP-5);
    Alternative:

    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Homodimer; disulfide-linked. Forms phosphorylated oligomer aggregates on Wnt-signaling (By similarity). Component of a Wnt-signaling complex that contains a WNT protein, a FZD protein and LRP5 or LRP6. Interacts with FZD8; the interaction is formed on WNT-binding and signaling. Interacts (via the phosphorylated PPPSP motif domains) with AXIN1; the interaction prevents inhibition of beta-catenin phosphorylation and signaling and is enhanced in the presence of GSK3B and WNT1 or WNT3A. Interacts (via beta-propeller regions 3 and 4) with DKK1; the interaction, enhanced by MESD and/or KREMEN, inhibits beta-catenin signaling by preventing GSK3-mediated phosphorylation of the PPPSP motifs and subsequent, AXIN1 binding. Interacts with MESD; the interaction prevents the formation of LRP5 aggregates, targets LRP5 to the plasma membrane and, when complexed with KREMEN2, increases DKK1 binding. Interacts with CSNK1E. Interacts with SOST; the interaction antagonizes canonical Wnt signaling. Interacts with APCDD1.
    Function:
    Component of the Wnt-Fzd-LRP5-LRP6 complex that triggers beta-catenin signaling through inducing aggregation of receptor-ligand complexes into ribosome-sized signalsomes. Cell-surface coreceptor of Wnt/beta-catenin signaling, which plays a pivotal role in bone formation. The Wnt-induced Fzd/LRP6 coreceptor complex recruits DVL1 polymers to the plasma membrane which, in turn, recruits the AXIN1/GSK3B-complex to the cell surface promoting the formation of signalsomes and inhibiting AXIN1/GSK3-mediated phosphorylation and destruction of beta-catenin. Appears be required for postnatal control of vascular regression in the eye. Required for posterior patterning of the epiblast during gastrulation.
    Subcellular Location:
    Membrane Single-pass type I membrane protein Endoplasmic reticulum Chaperoned to the plasma membrane by MESD.
    Protein Attributes:
    Sequence length:
    1615
    Sequence:
    50:
    MEAAPPGPPW | PLLLLLLLLL | ALCGCPAPAA | ASPLLLFANR | RDVRLVDAGG | 
    100:
    VKLESTIVVS | GLEDAAAVDF | QFSKGAVYWT | DVSEEAIKQT | YLNQTGAAVQ | 
    150:
    NVVISGLVSP | DGLACDWVGK | KLYWTDSETN | RIEVANLNGT | SRKVLFWQDL | 
    200:
    DQPRAIALDP | AHGYMYWTDW | GETPRIERAG | MDGSTRKIIV | DSDIYWPNGL | 
    250:
    TIDLEEQKLY | WADAKLSFIH | RANLDGSFRQ | KVVEGSLTHP | FALTLSGDTL | 
    300:
    YWTDWQTRSI | HACNKRTGGK | RKEILSALYS | PMDIQVLSQE | RQPFFHTRCE | 
    350:
    EDNGGCSHLC | LLSPSEPFYT | CACPTGVQLQ | DNGRTCKAGA | EEVLLLARRT | 
    400:
    DLRRISLDTP | DFTDIVLQVD | DIRHAIAIDY | DPLEGYVYWT | DDEVRAIRRA | 
    450:
    YLDGSGAQTL | VNTEINDPDG | IAVDWVARNL | YWTDTGTDRI | EVTRLNGTSR | 
    500:
    KILVSEDLDE | PRAIALHPVM | GLMYWTDWGE | NPKIECANLD | GQERRVLVNA | 
    550:
    SLGWPNGLAL | DLQEGKLYWG | DAKTDKIEVI | NVDGTKRRTL | LEDKLPHIFG | 
    600:
    FTLLGDFIYW | TDWQRRSIER | VHKVKASRDV | IIDQLPDLMG | LKAVNVAKVV | 
    650:
    GTNPCADRNG | GCSHLCFFTP | HATRCGCPIG | LELLSDMKTC | IVPEAFLVFT | 
    700:
    SRAAIHRISL | ETNNNDVAIP | LTGVKEASAL | DFDVSNNHIY | WTDVSLKTIS | 
    750:
    RAFMNGSSVE | HVVEFGLDYP | EGMAVDWMGK | NLYWADTGTN | RIEVARLDGQ | 
    800:
    FRQVLVWRDL | DNPRSLALDP | TKGYIYWTEW | GGKPRIVRAF | MDGTNCMTLV | 
    850:
    DKVGRANDLT | IDYADQRLYW | TDLDTNMIES | SNMLGQERVV | IADDLPHPFG | 
    900:
    LTQYSDYIYW | TDWNLHSIER | ADKTSGRNRT | LIQGHLDFVM | DILVFHSSRQ | 
    950:
    DGLNDCMHNN | GQCGQLCLAI | PGGHRCGCAS | HYTLDPSSRN | CSPPTTFLLF | 
    1000:
    SQKSAISRMI | PDDQHSPDLI | LPLHGLRNVK | AIDYDPLDKF | IYWVDGRQNI | 
    1050:
    KRAKDDGTQP | FVLTSLSQGQ | NPDRQPHDLS | IDIYSRTLFW | TCEATNTINV | 
    1100:
    HRLSGEAMGV | VLRGDRDKPR | AIVVNAERGY | LYFTNMQDRA | AKIERAALDG | 
    1150:
    TEREVLFTTG | LIRPVALVVD | NTLGKLFWVD | ADLKRIESCD | LSGANRLTLE | 
    1200:
    DANIVQPLGL | TILGKHLYWI | DRQQQMIERV | EKTTGDKRTR | IQGRVAHLTG | 
    1250:
    IHAVEEVSLE | EFSAHPCARD | NGGCSHICIA | KGDGTPRCSC | PVHLVLLQNL | 
    1300:
    LTCGEPPTCS | PDQFACATGE | IDCIPGAWRC | DGFPECDDQS | DEEGCPVCSA | 
    1350:
    AQFPCARGQC | VDLRLRCDGE | ADCQDRSDEA | DCDAICLPNQ | FRCASGQCVL | 
    1400:
    IKQQCDSFPD | CIDGSDELMC | EITKPPSDDS | PAHSSAIGPV | IGIILSLFVM | 
    1450:
    GGVYFVCQRV | VCQRYAGANG | PFPHEYVSGT | PHVPLNFIAP | GGSQHGPFTG | 
    1500:
    IACGKSMMSS | VSLMGGRGGV | PLYDRNHVTG | ASSSSSSSTK | ATLYPPILNP | 
    1550:
    PPSPATDPSL | YNMDMFYSSN | IPATARPYRP | YIIRGMAPPT | TPCSTDVCDS | 
    1600:
    DYSASRWKAS | KYYLDLNSDS | DPYPPPPTPH | SQYLSAEDSC | PPSPATERSY | 
    1615:
    FHLFPPPPSP | CTDSS
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    KEGG:
    UniGene:
    MIM:
    SMR:
    Pfam:
    String:
    Uniprot:
     
    FOR
    ELISA Kit for Human LRP-5
    Cat.:
    E3681h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human LRP-5
    Cat.:
    E3681m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human LRP-5
    Cat.:
    U3681m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human LRP-5
    Cat.:
    U3681h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human LRP-5
    Cat.:
    P3681Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human LRP-5
    Cat.:
    P3681Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human LRP-5
    Monoclonal Antibody for Human LRP-5
    Protein for Human LRP-5
    Cat.:
    R3681h
    Price:
    Please sign in first.
    Packing:
    1mg
    Purity:
    >90%
    Protein for Human LRP-5

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity."
      Dong Y. , Lathrop W. , Weaver D. , Qiu Q. , Cini J. , Bertolini D. , Chen D.
      Biochem. Biophys. Res. Commun.251:784-790(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];TISSUE SPECIFICITY
      tissue: Osteoblast.
    2. 2.
      "Cloning of a novel member of the low-density lipoprotein receptor family."
      Hey P.J. , Twells R.C.J. , Phillips M.S. , Nakagawa Y. , Brown S.D. , Kawaguchi Y. , Cox R. , Xie G. , Dugan V. , Hammond H. , Metzker M.L. , Todd J.A. , Hess J.F.
      Gene216:103-111(1998) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];VARIANT VAL-1525
      tissue: Osteoblast.
    3. 3.
      "The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13."
      Twells R.C.J. , Metzker M.L. , Brown S.D. , Cox R. , Garey C. , Hammond H. , Hey P.J. , Levy E. , Nakagawa Y. , Philips M.S. , Todd J.A. , Hess J.F.
      Genomics72:231-242(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    4. 4.
      "Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion."
      Fujino T. , Asaba H. , Kang M.J. , Ikeda Y. , Sone H. , Takada S. , Kim D.H. , Ioka R.X. , Ono M. , Tomoyori H. , Okubo M. , Murase T. , Kamataki A. , Yamamoto J. , Magoori K. , Takahashi S. , Miyamoto Y. , Oishi H. , more...
      Proc. Natl. Acad. Sci. U.S.A.100:229-234(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA];VARIANT VAL-1330
    5. 5.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    6. 6.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    7. 7.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
    8. 8.
      "Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6."
      Semenov M.V. , Tamai K. , Brott B.K. , Kuhl M. , Sokol S. , He X.
      Curr. Biol.11:951-961(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH FZD8 IN WNT-FZD-LRP5-LRP6 COMPLEX;INTERACTION WITH DKK1;FUNCTION
    9. 9.
      "Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway."
      Mao J. , Wang J. , Liu B. , Pan W. , Farr G.H. III , Flynn C. , Yuan H. , Takada S. , Kimelman D. , Li L. , Wu D.
      Mol. Cell7:801-809(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;INTERACTION WITH AXIN1
    10. 10.
      "A mechanism for Wnt coreceptor activation."
      Tamai K. , Zeng X. , Liu C. , Zhang X. , Harada Y. , Chang Z. , He X.
      Mol. Cell13:149-156(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: FUNCTION;PHOSPHORYLATION;INTERACTION WITH AXIN1
    11. 11.
      "The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd."
      Zhang Y. , Wang Y. , Li X. , Zhang J. , Mao J. , Li Z. , Zheng J. , Li L. , Harris S. , Wu D.
      Mol. Cell. Biol.24:4677-4684(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH MESD;CHARACTERIZATION OF VARIANT HBM VAL-171
    12. 12.
      "Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling."
      Li X. , Zhang Y. , Kang H. , Liu W. , Liu P. , Zhang J. , Harris S.E. , Wu D.
      J. Biol. Chem.280:19883-19887(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH DKK1 AND SOST;FUNCTION
    13. 13.
      "SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor."
      Semenov M. , Tamai K. , He X.
      J. Biol. Chem.280:26770-26775(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH WNT1 IN THE WNT-FZD-LRP5-LRP6 COMPLEX;INTERACTION WITH SOST
    14. 14.
      "Negative regulation of LRP6 function by casein kinase I epsilon phosphorylation."
      Swiatek W. , Kang H. , Garcia B.A. , Shabanowitz J. , Coombs G.S. , Hunt D.F. , Virshup D.M.
      J. Biol. Chem.281:12233-12241(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CSNK1E
    15. 15.
      "Requirement for natively unstructured regions of mesoderm development candidate 2 in promoting low-density lipoprotein receptor-related protein 6 maturation."
      Koduri V. , Blacklow S.C.
      Biochemistry46:6570-6577(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH MESD
    16. 16.
      "A cell-based Dkk1 binding assay reveals roles for extracellular domains of LRP5 in Dkk1 interaction and highlights differences between wild-type and the high bone mass mutant LRP5(G171V)."
      Murrills R.J. , Matteo J.J. , Bhat B.M. , Coleburn V.E. , Allen K.M. , Chen W. , Damagnez V. , Bhat R.A. , Bex F.J. , Bodine P.V.
      J. Cell. Biochem.108:1066-1075(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH DKK1 AND MESD;CHARACTERIZATION OF VARIANT VAL-171
    17. 17.
      "APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex."
      Shimomura Y. , Agalliu D. , Vonica A. , Luria V. , Wajid M. , Baumer A. , Belli S. , Petukhova L. , Schinzel A. , Brivanlou A.H. , Barres B.A. , Christiano A.M.
      Nature464:1043-1047(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH APCDD1
    18. 19.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HBM VAL-171
    19. 20.
      "High bone density due to a mutation in LDL-receptor-related protein 5."
      Boyden L.M. , Mao J. , Belsky J. , Mitzner L. , Farhi A. , Mitnick M.A. , Wu D. , Insogna K. , Lifton R.P.
      N. Engl. J. Med.346:1513-1521(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HBM VAL-171;CHARACTERIZATION OF VARIANT HBM VAL-171
    20. 21.
      "Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density."
      Van Wesenbeeck L. , Cleiren E. , Gram J. , Beals R.K. , Benichou O. , Scopelliti D. , Key L. , Renton T. , Bartels C. , Gong Y. , Warman M.L. , de Vernejoul M.-C. , Bollerslev J. , Van Hul W.
      Am. J. Hum. Genet.72:763-771(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OPTA1 TYR-111; ARG-171; THR-242 AND ILE-253;VARIANTS WENHY THR-214; VAL-214 AND THR-242;VARIANT VBCH2 THR-242;VARIANTS 18-LEU--LEU-20 DEL; LEU-20 INS; ARG-89; MET-667 AND VAL-1330
    21. 22.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS EVR4 MET-173; HIS-1168 AND GLY-1361;VARIANT VAL-1525
    22. 23.
      "Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites."
      Ferrari S.L. , Deutsch S. , Choudhury U. , Chevalley T. , Bonjour J.-P. , Dermitzakis E.T. , Rizzoli R. , Antonarakis S.E.
      Am. J. Hum. Genet.74:866-875(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS MET-667 AND VAL-1330
    23. 24.
      "Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5."
      Jiao X. , Ventruto V. , Trese M.T. , Shastry B.S. , Hejtmancik J.F.
      Am. J. Hum. Genet.75:878-884(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS EVR4 GLN-570; GLY-752 AND LYS-1367
    24. 25.
      "LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density."
      Mizuguchi T. , Furuta I. , Watanabe Y. , Tsukamoto K. , Tomita H. , Tsujihata M. , Ohta T. , Kishino T. , Matsumoto N. , Minakami H. , Niikawa N. , Yoshiura K.
      J. Hum. Genet.49:80-86(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS ARG-89 AND VAL-1330;FUNCTION;INVOLVEMENT IN OSTEOPOROSIS
    25. 26.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OPPG ASN-203; MET-244; PHE-307; TRP-348; GLN-353; LEU-356; LYS-390; GLU-400; ARG-404; ASN-434; LYS-460; GLN-494; VAL-520; TRP-570; ARG-610; ASN-683; HIS-733; TYR-1099; CYS-1113 AND ASP-1401;CHARACTERIZATION OF VARIANTS OPPG MET-244; LEU-356; LYS-390; ARG-404; ASN-434; VAL-520 AND ARG-610;CHARACTERIZATION OF VARIANTS EVR4 MET-173; GLN-570; HIS-1168; GLY-1361 AND LYS-1367
    26. 27.
      "Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes."
      Qin M. , Hayashi H. , Oshima K. , Tahira T. , Hayashi K. , Kondo H.
      Hum. Mutat.26:104-112(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS EVR4 PHE-145; CYS-444; THR-522; MET-535; ARG-610; CYS-617; ALA-798 AND ASP-1121;VARIANTS VAL-97 AND MET-1540
    27. 28.
      "Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children."
      Hartikka H. , Makitie O. , Mannikko M. , Doria A.S. , Daneman A. , Cole W.G. , Ala-Kokko L. , Sochett E.B.
      J. Bone Miner. Res.20:783-789(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS PRIMARY OSTEOPOROSIS THR-29 AND GLN-1036
    28. 29.
      "Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation."
      Rickels M.R. , Zhang X. , Mumm S. , Whyte M.P.
      J. Bone Miner. Res.20:878-885(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HBM MET-154
    29. 30.
      "Missense mutations in LRP5 are not a common cause of idiopathic osteoporosis in adult men."
      Crabbe P. , Balemans W. , Willaert A. , van Pottelbergh I. , Cleiren E. , Coucke P.J. , Ai M. , Goemaere S. , van Hul W. , de Paepe A. , Kaufman J.-M.
      J. Bone Miner. Res.20:1951-1959(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS IDIOPATHIC OSTEOPOROSIS LEU-356 AND LEU-455;VARIANT THR-1537;CHARACTERIZATION OF VARIANTS IDIOPATHIC OSTEOPOROSIS LEU-356 AND LEU-455;CHARACTERIZATION OF VARIANT THR-1537
    30. 31.
      "A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene."
      Cheung W.M.W. , Jin L.Y. , Smith D.K. , Cheung P.T. , Kwan E.Y.W. , Low L. , Kung A.W.C.
      Bone39:470-476(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS OPPG ARG-478 AND CYS-504
    31. 32.
      "Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5."
      Downey L.M. , Bottomley H.M. , Sheridan E. , Ahmed M. , Gilmour D.F. , Inglehearn C.F. , Reddy A. , Agrawal A. , Bradbury J. , Toomes C.
      Br. J. Ophthalmol.90:1163-1167(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT EVR4 ARG-550
    32. 33.
      "A novel mutation in the LRP5 gene is associated with osteoporosis-pseudoglioma syndrome."
      Barros E.R. , Dias da Silva M.R. , Kunii I.S. , Hauache O.M. , Lazaretti-Castro M.
      Osteoporos. Int.18:1017-1018(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT OPPG ILE-531
    33. 34.
      "Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates."
      Streeten E.A. , McBride D. , Puffenberger E. , Hoffman M.E. , Pollin T.I. , Donnelly P. , Sack P. , Morton H.
      Bone43:584-590(2008) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT OPPG ALA-409
    34. 35.
      "A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats."
      Chung B.D. , Kayserili H. , Ai M. , Freudenberg J. , Uzumcu A. , Uyguner O. , Bartels C.F. , Honing S. , Ramirez A. , Hanisch F.G. , Nurnberg G. , Nurnberg P. , Warman M.L. , Wollnik B. , Kubisch C. , Netzer C.
      Hum. Mutat.30:641-648(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT 15-LEU--LEU-20 DEL
    35. 36.
      "Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy."
      Boonstra F.N. , van Nouhuys C.E. , Schuil J. , de Wijs I.J. , van der Donk K.P. , Nikopoulos K. , Mukhopadhyay A. , Scheffer H. , Tilanus M.A.D. , Cremers F.P.M. , Hoefsloot L.H.
      Invest. Ophthalmol. Vis. Sci.50:4379-4385(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS EVR4 ALA-511 AND TRP-805
    36. 37.
      "Overview of the mutation spectrum in familial exudative vitreoretinopathy and Norrie disease with identification of 21 novel variants in FZD4, LRP5, and NDP."
      Nikopoulos K. , Venselaar H. , Collin R.W.J. , Riveiro-Alvarez R. , Boonstra F.N. , Hooymans J.M. , Mukhopadhyay A. , Shears D. , van Bers M. , de Wijs I.J. , van Essen A.J. , Sijmons R.H. , Tilanus M.A.D. , van Nouhuys C.E. , Ayuso C. , Hoefsloot L.H. , Cremers F.P.M.
      Hum. Mutat.31:656-666(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS EVR4 LYS-441 AND PHE-1253
    37. 38.
      "Identification of two novel LRP5 mutations in families with familial exudative vitreoretinopathy."
      Fei P. , Zhang Q. , Huang L. , Xu Y. , Zhu X. , Tai Z. , Gong B. , Ma S. , Yao Q. , Li J. , Zhao P. , Yang Z.
      Mol. Vis.20:395-409(2014) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT PRO-816;VARIANTS EVR4 THR-422; PRO-540 AND MET-852;CHARACTERIZATION OF VARIANTS EVR4 THR-422; PRO-540 AND MET-852;CHARACTERIZATION OF VARIANT PRO-816
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter